Following our previous findings of the reduced expression of JAM3 in tumor-draining LN LECs, we have herein observed a similar reduction in Jam3 expression in the floor LECs in the inflammation model, which is in agreement with previous studies suggesting that lower levels of JAM3 are associated with decreased vascular permeability [15,65,66]. Here, JAM3 is linked to neoplasm.